NEWS
Quantinuum selected by DARPA to advance to first stage of Quantum Benchmarking Initiative
As validated in a recent independent benchmarking study by a group of institutions at the forefront of quantum computing research, Quantinuum’ s quantum systems are the highest performing in the industry.
Last year, Quantinuum published its development roadmap, outlining a path to a universal, fully-fault tolerant quantum computer by 2029.
Quantinuum has been selected by the Defense Advanced
Research Projects Agency( DARPA), a research and development agency of the United States Department of Defense, to participate in the first stage of the agency’ s Quantum Benchmarking Initiative( QBI).
QBI aims to assess the feasibility of building an industrially useful quantum computer by 2033.
Successful QBI performers will advance through stages A, B and C; Stage A requires performers to describe their utility-scale quantum computer with a path to near-term realization, where utility-scale means the computational value exceeds costs.
Beyond this public roadmap, Quantinuum plans to scale to even larger machines in the early part of the 2030s, aligning with the objectives of QBI.
“ We are honored to collaborate with DARPA and look forward to working closely with their test and evaluation team as they assess our roadmap and technological approach,” said Dr Rajeeb Hazra, President and CEO, Quantinuum.
“ With our roadmap firmly on track, we are confident in our ability to deliver on DARPA’ s objectives for QBI.”
Microsoft and NVIDIA will take part in Quantinuum’ s Stage A effort, building on their long-standing collaborations with Quantinuum in advancing commercially scalable quantum computing.
CAS and Cleveland Clinic collaborate to accelerate research using advanced AI and quantum computing
CAS and Cleveland Clinic have confirmed that the first strategic focus area of their collaboration will aim to advance research on health, wellness and healthy aging.
The initial projects the organizations are discussing will focus on discovering drugs for brain health, a priority characterized by the relative lack of effective treatments that can modify Alzheimer’ s disease due to its complex nature.
Lara Jehi, M. D., Director of Research Information, Cleveland Clinic, said:“ By combining our strengths, we seek to generate high-quality medical data, validate scientific models and integrate research to ultimately improve patient care and manage chronic diseases.”
This effort will leverage the CAS Content Collection, the world’ s most comprehensive curated scientific information resource, with advanced technologies, including new AI and quantum computing models. As part of its partnership with IBM, Cleveland Clinic has the IBM Quantum System One, the world’ s first quantum computer entirely dedicated to health research.
The collaborators plan to build and train disease-specific models, starting with Alzheimer’ s, and will be focused on advancing preventive and predictive strategies and potentially translating them to other chronic diseases in the future.
“ CAS is pleased to partner with Cleveland Clinic, an institution recognized for its exceptional research and innovation,” said Manuel Guzman, president of CAS.“ We recognize that it takes 17 years for a scientific discovery in a laboratory to become an approved test or therapy and we are confident that together we can close that gap.”
10 INTELLIGENTCIO NORTH AMERICA www. intelligentcio. com